Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives

Author： Dufour Marc   Dormond-Meuwly Anne   Demartines Nicolas   Dormond Olivier  

Publisher： MDPI

E-ISSN： 2072-6694|3|2|2478-2500

ISSN： 2072-6694

Source： Cancers, Vol.3, Iss.2, 2011-05, pp. : 2478-2500

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis

By Lawrence Jessica   Nho Richard  

International Journal of Molecular Sciences, Vol. 19, Iss. 3, 2018-03 ,pp. : 778-778

MDPI

Access to resources Recommend Favorite

Chemical Inhibitors and microRNAs (miRNA) Targeting the Mammalian Target of Rapamycin (mTOR) Pathway: Potential for Novel Anticancer Therapeutics

By AlQurashi Naif   Hashimi Saeed M.   Wei Ming Q.  

International Journal of Molecular Sciences, Vol. 14, Iss. 2, 2013-02 ,pp. : 3874-3900

MDPI

Access to resources Recommend Favorite

Oncogenic Signalling through Mechanistic Target of Rapamycin (mTOR): A Driver of Metabolic Transformation and Cancer Progression

By Rad Ellie   Murray James T.   Tee Andrew R.  

Cancers, Vol. 10, Iss. 1, 2018-01 ,pp. : 5-5

MDPI

Access to resources Recommend Favorite

mTOR Cross-Talk in Cancer and Potential for Combination Therapy

By Conciatori Fabiana   Ciuffreda Ludovica   Bazzichetto Chiara   Falcone Italia   Pilotto Sara   Bria Emilio   Cognetti Francesco   Milella Michele  

Cancers, Vol. 10, Iss. 1, 2018-01 ,pp. : 23-23

MDPI

Access to resources Recommend Favorite

mTOR Pathways in Cancer and Autophagy

By Paquette Mathieu   El-Houjeiri Leeanna   Pause Arnim  

Cancers, Vol. 10, Iss. 1, 2018-01 ,pp. : 18-18

MDPI

Access to resources Recommend Favorite